Sarepta Therapeutics, Inc. (SRPT)
20.78
-2.24
(-9.75%)
USD |
NASDAQ |
May 07, 16:00
20.73
-0.06
(-0.26%)
After-Hours: 05:04
Sarepta Therapeutics Research and Development Expense (Annual) : 1.493B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| PTC Therapeutics, Inc. | 455.25M |
| Keros Therapeutics, Inc. | 127.09M |
| REGENXBIO, Inc. | 212.68M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |